PRNewswire

The PRIMED study found a way to reduce treatment-related side effects among participants, decreasing dose reductions, treatment interruptions, and permanent discontinuations. The strategic alliance between MEDSIR and Oncoclínicas has enabled the company to present 13 studies at the 2024 ASCO Annual

SHANGHAI and CHICAGO, June 1, 2024 /PRNewswire/ — GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the phase II trial data of KROCUS Study, fulzerasib (GFH925, KRAS G12C inhibitor) in combination with c

Long-Term Follow-Up Data Signal Promising Progression-Free Survival (PFS) for Selinexor in the Maintenance Setting with Median PFS of 28.4 Months in the TP53 Wild-Type and 39.5 Months in the Proficient Mismatched Repair Status (pMMR) TP53 Wild-Type Exploratory Subgroups Q-TWiST, an Important Metric

ONTARIO, Calif., June 1, 2024 /PRNewswire/ — Mark your calendars, grill masters! Z Grills, the innovator in premium wood pellet grills, is sizzling up summer with a groundbreaking promotion that’s sure to leave your taste buds – and wallet – happy. This June 6th, Z Grills kicks off t

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: